Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Secures Distribution Rights to New X-Man Cell Lines from Japanese University

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK firm Horizon Discovery today announced it has been granted an exclusive worldwide license by Public University Corporation Yokohama City University (YCU) for 50 new X-Man cell lines.

The cell lines are focused on DNA repair and include important double knockout cell lines, Horizon said, noting that they complement the UK firm's existing X-Man DNA repair panel in the HCT-116 colon cell line.

The new lines are in the NALM-6 cell line, a B-cell derived line. As a result of the deal, Horizon's panel of X-Man cell lines now includes B-cells.

Horizon will pay YCU upfront and ongoing royalty payments as part of the deal. In exchange, it receives the exclusive, worldwide rights to distribute the cell lines. The agreement supports Horizon's strategy to generate at least 2,500 new X-man models of cancer, neurodegenerative, and cardiovascular disease, it said.

The new cell lines will enable researchers to learn more about the role of DNA repair in leukemia, while providing a new model for other diseases. Horizon added that they will provide insight into how genetic diseases manifest themselves in patients and help rationalize many aspects of new-drug development.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.